Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response

Cell Death and Differentiation

Volumn 21, Issue 9, 2014, Pages 1377-1387

  Marcel, V ^a   Fernandes, K ^a   Terrier, O ^a   Lane, D P ^b   Bourdon, J C ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b P53 Laboratory (p53Lab)   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN P53; TP53 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; HUMANS; MCF-7 CELLS; PROTEIN ISOFORMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84905909213     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.73     Document Type: Article

References (23)

1. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40: 1413-1415.
2. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456: 470-476.
3. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; Vol. 19: 2122-2137.
4. Marcel V, Dichtel-Danjoy ML, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 18: 1815-1824 2011.
5. Lane D, Levine A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2010; 2: a000893.
6. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ et al. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 2009; 11: 1135-1142.
7. Bourdon JC, Khoury MP, Diot A, Baker L, Fernandes K, Aoubala M et al. p53 mutant breast cancer patients expressing p53gamma have as good a prognosis as wild-type p53 breast cancer patients. Breast Cancer Res 2011; 13: R7.
8. Camus S, Ménendez S, Fernandes K, Kua N, Liu G, Xirodimas DP et al. The p53 isoforms are differentially modified by Mdm2. Cell Cycle 2012; 11: 1646-1655.
9. Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM et al. Downregulation of splicing factor SRSF3 induces p53beta, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene 2012; 32: 2792-2798.
10. Mermoud JE, Cohen PT, Lamond AI. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 1994; 13: 5679-5688.
11. Ghosh G, Adams JA. Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J 2011; 278: 587-597.
12. Muraki M, Ohkawara B, Hosoya T, Onogi H, Koizumi J, Koizumi T et al. Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem 2004; 279: 24246-24254.
13. Nishida A, Kataoka N, Takeshima Y, Yagi M, Awano H, Ota M et al. Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat Commun 2011; 2: 308.
14. Allende-Vega N, Dayal S, Agarwala U, Sparks A, Bourdon JC, Saville MK. p53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene 2012; 32: 1-14.
15. Marcel V, Petit I, Murray-Zmijewski F, Goullet de Rugy T, Fernandes K, Meuray V et al. Diverse p63 and p73 isoforms regulate Delta133p53 expression through modulation of the internal TP53 promoter activity. Cell Death Differ 2011; 19: 816-826.
16. Marcel V et al. in p53 protocols (3rd edn.) Vol. 962 Methods in Molecular Biology (ed Deb S and Deb SP) Ch. 2, (Spriner Science and Buisness Media New York, 2012).
17. Khoury MP et al. in p53 protocols (3rd edn.) Vol. 962 Methods in Molecular Biology (ed Deb S and Deb SP) Ch. 1, (Springer Science and Buisness Media New York, 2012).
18. Cowill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC et al. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 1996; 15: 265-275.
19. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639-649.
20. Zhang Z, Krainer AR. Involvement of SR proteins in mRNA surveillance. Mol Cell 2004; 16: 597-607.
21. Sun S, Zhang Z, Sinha R, Karni R, Krainer AR. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol 2010; 17: 306-312.
22. Silden E, Hjelle SM, Wergeland L, Sulen A, Andresen V, Bourdon JC et al. Expression of TP53 isoforms p53beta or p53gamma enhances chemosensitivity in TP53(null) cell lines. PLoS One 2013; 8: e56276.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) Method. Methods 2001; 25: 402-408.